South Korea · Delayed Price · Currency is KRW OPTUS Pharmaceutical Statistics
Total Valuation
KOSDAQ:131030 has a market cap or net worth of KRW 100.94 billion. The enterprise value is 60.08 billion.
| Market Cap | 100.94B |
| Enterprise Value | 60.08B |
Important Dates
The next estimated earnings date is Friday, October 23, 2026.
| Earnings Date | Oct 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:131030 has 17.65 million shares outstanding. The number of shares has increased by 7.58% in one year.
| Current Share Class | 17.65M |
| Shares Outstanding | 17.65M |
| Shares Change (YoY) | +7.58% |
| Shares Change (QoQ) | +3.25% |
| Owned by Insiders (%) | 0.74% |
| Owned by Institutions (%) | 3.81% |
| Float | 11.02M |
Valuation Ratios
The trailing PE ratio is 6.85.
| PE Ratio | 6.85 |
| Forward PE | n/a |
| PS Ratio | 1.07 |
| PB Ratio | 0.56 |
| P/TBV Ratio | 0.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 5.12 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 4.37 |
| EV / Sales | 0.64 |
| EV / EBITDA | 3.96 |
| EV / EBIT | 5.95 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.03, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.03 |
| Quick Ratio | 3.26 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | -0.04 |
| Interest Coverage | 139.56 |
Financial Efficiency
Return on equity (ROE) is 8.40% and return on invested capital (ROIC) is 7.17%.
| Return on Equity (ROE) | 8.40% |
| Return on Assets (ROA) | 3.42% |
| Return on Invested Capital (ROIC) | 7.17% |
| Return on Capital Employed (ROCE) | 5.58% |
| Weighted Average Cost of Capital (WACC) | 3.93% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.51 |
| Inventory Turnover | 2.90 |
Taxes
| Income Tax | -60.48M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.77% in the last 52 weeks. The beta is -0.06, so KOSDAQ:131030's price volatility has been lower than the market average.
| Beta (5Y) | -0.06 |
| 52-Week Price Change | -28.77% |
| 50-Day Moving Average | 5,718.70 |
| 200-Day Moving Average | 7,776.28 |
| Relative Strength Index (RSI) | 48.07 |
| Average Volume (20 Days) | 37,394 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:131030 had revenue of KRW 94.47 billion and earned 13.75 billion in profits. Earnings per share was 835.29.
| Revenue | 94.47B |
| Gross Profit | 53.05B |
| Operating Income | 10.10B |
| Pretax Income | 13.69B |
| Net Income | 13.75B |
| EBITDA | 15.18B |
| EBIT | 10.10B |
| Earnings Per Share (EPS) | 835.29 |
Balance Sheet
The company has 42.15 billion in cash and 1.29 billion in debt, with a net cash position of 40.85 billion or 2,315.17 per share.
| Cash & Cash Equivalents | 42.15B |
| Total Debt | 1.29B |
| Net Cash | 40.85B |
| Net Cash Per Share | 2,315.17 |
| Equity (Book Value) | 180.14B |
| Book Value Per Share | 10,381.70 |
| Working Capital | 50.98B |
Cash Flow
In the last 12 months, operating cash flow was 19.73 billion and capital expenditures -53.40 billion, giving a free cash flow of -33.68 billion.
| Operating Cash Flow | 19.73B |
| Capital Expenditures | -53.40B |
| Depreciation & Amortization | 5.08B |
| Net Borrowing | -802.96M |
| Free Cash Flow | -33.68B |
| FCF Per Share | -1,908.34 |
Margins
Gross margin is 56.16%, with operating and profit margins of 10.70% and 14.55%.
| Gross Margin | 56.16% |
| Operating Margin | 10.70% |
| Pretax Margin | 14.49% |
| Profit Margin | 14.55% |
| EBITDA Margin | 16.07% |
| EBIT Margin | 10.70% |
| FCF Margin | n/a |
Dividends & Yields
KOSDAQ:131030 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.58% |
| Shareholder Yield | -7.58% |
| Earnings Yield | 13.62% |
| FCF Yield | -33.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KOSDAQ:131030 has an Altman Z-Score of 6.45 and a Piotroski F-Score of 7.
| Altman Z-Score | 6.45 |
| Piotroski F-Score | 7 |